Meyron

Reference summary — not medical advice or a personal risk estimate.

Dantron (Chrysazin; 1,8-Dihydroxyanthraquinone)

Group 2B — possibly carcinogenicMedications & MedicalchemicalEvidence: limited_in_humans

Summary

Classified by IARC as Group 2B — possibly carcinogenic to humans. Evidence is limited. (Vol 50, 1990)

Regional relevance

global

historical

Sources

Consumer references

Third-party tools some readers use alongside primary evidence. Meyron doesn't endorse them; we link them because you'll otherwise hit them anyway.